Skip to content
Open access

Establishing comprehensive oncology-haematology pharmacy care for paediatric bone marrow transplantation in sickle cell disease: Procedural insights from a Delphi study conducted in Tanzania.

Sep 2026 · Journal of Oncology Pharmacy Practice · pp. 10781552261481538 · 0 citations · 34 references
Medicine

TL;DR

The Delphi findings highlight staffing and infrastructure as top priorities for establishing BMT and HSCT services in resource-limited settings and the recommended guidelines and protocols can enhance service delivery and improve patient outcomes.

Abstract

BackgroundHematopoietic stem cell transplantation (HSCT) is vital for treating blood disorders, yet Low- and Middle-Income Countries (LMICs) often lack adequate Bone Marrow Transplant (BMT) pharmacy services. This study aims to reach consensus among oncology pharmacy experts on the essential staff, infrastructure, supplies, and safety/control measures required to establish BMT pharmacy services in LMICs.MethodologyThe Delphi method was employed to evaluate and achieve consensus on BMT pharmacy services at Benjamin Mkapa Hospital in Tanzania, involving 11 oncology pharmacy personnel.ResultsIn the initial round, participants responded to 10 open-ended questions concerning staffing, infrastructure, supplies, medicines, safety, and quality assurance. The second round focused on achieving consensus, breaking down the domains into 14 specific points. Consensus scores varied from 64% (neutral) for safety and quality assurance to 96% for staffing levels, with consensus reached at 66.7%. The third round concentrated on prioritization, identifying staffing and infrastructure as high priorities, which received a score of 46%. Safety and quality assurance garnered the lowest score at 9%. Participants proposed two guidelines, three protocols, and 21 standard operating procedures (SOPs). Additionally, they suggested 14 essential medicines, 56 adjunctive medicines, 22 medical devices, and at least two Class III biosafety cabinets, which are crucial for establishing BMT pharmacy units and HSCT services in resource-limited settings. These resources were categorized into those already established at BMH and those that emerged from participant consensus.ConclusionsThe Delphi findings highlight staffing and infrastructure as top priorities for establishing BMT and HSCT services in resource-limited settings. Addressing safety and quality assurance is also crucial. The recommended guidelines and protocols can enhance service delivery and improve patient outcomes.

Read PDF

Similar papers

Open access Aug 2026

Challenges of Treatment Decisions for Children With Hematological Malignancies Who Relapse After Hematopoietic Stem Cell Transplant: A Health Care Provider Perspective

Background When a child or adolescent's disease relapses following hematopoietic stem cell transplantation (HSCT), families are often presented with the complex decision to pursue further treatment with curative intent. This study aims to describe the experiences of health care professionals (HCPs) regarding choices af...

D. Tomlinson, Sonia Lucchetta, S. Alexander et al. · 0 citations
Open access Jun 2026

Immunotherapy Landscape for Acute Lymphoblastic Leukaemia (ALL) in Malaysia: A Qualitative Study Among Healthcare Professionals From Two National Referral Centres

Introduction Relapsed or refractory B-cell acute lymphoblastic leukaemia (B-ALL) carries a poor prognosis in adults. Although immunotherapies have expanded treatment options, access to these life-extending therapies remains a challenge in many resource-constrained healthcare systems. This study explored healthcare prof...

Mei Pin Ngu, N. Shamsuddin, Hasniza Zaman Huri et al. · 0 citations
Sep 2026

Current Practices Regarding Prophylactic Enteral Nutrition in Hematopoietic Stem Cell Transplantation in Canada: A Quality Assurance Study.

Hematopoietic stem cell transplantation (HSCT) and its conditioning regimens negatively affect the gastrointestinal tract, causing complications that may limit oral intake. As a result, HSCT patients are at risk of malnutrition, with parenteral nutrition (PN) often being the default treatment. The American Society for...

Nada Mani, Karine Solomon, Tina Mezzacappa et al. · 0 citations
Open access Aug 2026

Transforming pediatric intensive care unit outcomes in pediatric hematology-oncology and hematopoietic stem cell transplantation through golden hour care in a low- and middle-income country: a 10-year analysis

ABSTRACT Objective: To evaluate the impact of a care improvement bundle focused on early intervention, communication, and multidisciplinary collaboration by comparing outcomes across two 5-year periods before and after its implementation. Methods: A single-center, retrospective study was conducted in the Onco-Critical...

I. Jayakumar, Milind Ballal, N. A. Reddy et al. · 0 citations
Open access Sep 2026

Haploidentical haematopoietic stem cell transplantation for thalassaemia major: A phase IV, open-label, single-centre trial.

We report the results of an open-label, single-centre phase 4 clinical trial evaluating haploidentical haematopoietic stem cell transplantation (Haplo-HSCT) in patients with transfusion-dependent thalassaemia (TDT). A total of 134 patients with TDT were enrolled; the median age was 8.7 years (interquartile range [IQR],...

Xiao-Xuan Lai, Rong-Rong Liu, Hongwen Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.